Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Norway has been experiencing significant growth in recent years.
Customer preferences: Norwegian customers have shown a strong preference for natural and holistic approaches to treating depressive disorders. They are increasingly seeking out alternative therapies such as acupuncture, herbal remedies, and mindfulness-based practices. This shift in customer preferences is driven by a desire for more personalized and holistic treatment options that address the underlying causes of depression, rather than just managing symptoms.
Trends in the market: One of the key trends in the Norwegian Depressive Disorders market is the increasing use of digital health solutions. Mobile applications and online platforms that offer mental health support and therapy have gained popularity among Norwegian consumers. These digital solutions provide convenience and accessibility, allowing individuals to access support and treatment from the comfort of their own homes. The use of telemedicine has also become more prevalent, enabling patients to consult with healthcare professionals remotely.Another trend in the market is the growing awareness and destigmatization of mental health issues in Norwegian society. There has been a concerted effort by both the government and non-profit organizations to raise awareness about depression and other mental health disorders. This increased awareness has led to more individuals seeking help and treatment for their depressive symptoms.
Local special circumstances: Norway has a well-developed healthcare system that provides universal access to healthcare services, including mental health care. The government has made significant investments in mental health services, ensuring that individuals have access to a range of treatment options. This has contributed to the growth of the Depressive Disorders market in the country.
Underlying macroeconomic factors: Norway has a high standard of living and a strong economy, which has contributed to the growth of the Depressive Disorders market. The country has a high disposable income, allowing individuals to afford the cost of treatment and therapy. Additionally, the Norwegian government provides subsidies and reimbursement for mental health services, making them more affordable for individuals.In conclusion, the Depressive Disorders market in Norway is experiencing growth due to customer preferences for natural and holistic approaches, the increasing use of digital health solutions, the destigmatization of mental health issues, the well-developed healthcare system, and the country's strong economy. These factors have created a favorable environment for the growth of the market in Norway.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights